Stock data
Aptevo Therapeutics Inc. (APVO)
Aptevo Therapeutics Inc. (APVO) reported net income of -US$25.97M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$26.31M | -US$25.97M | — |
| 2024 | — | — | -US$24.60M | -US$24.13M | — |
| 2023 | — | — | -US$28.88M | -US$17.41M | — |
| 2022 | US$3.11M | — | -US$28.64M | US$8.03M | — |
| 2021 | US$12.29M | — | -US$21.40M | -US$28.46M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$6.36M | — |
| 2026-03-31 | — | -US$6.70M | — |
| 2025-12-31 | — | -US$5.81M | — |
| 2025-09-30 | — | -US$7.55M | — |
| 2025-06-30 | — | -US$6.20M | — |
| 2025-03-31 | — | -US$6.41M | — |
| 2024-12-31 | — | -US$6.31M | — |
| 2024-09-30 | — | -US$5.10M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.